Latest news with #SageTapPoder
Globe and Mail
6 days ago
- Business
- Globe and Mail
STPCM Offers Accredited Investors Access to Pioneering Breast Imaging Innovation with FDA-Cleared Koning Vera™ Scanner
Sage Tap Poder Capital Management (STPCM) announced the official launch of a $5 million investment opportunity in Koning Health, the medical imaging company behind the groundbreaking Koning Vera™ 3D Breast CT Scanner. Sage Tap Poder Capital Management (STPCM) announced the official launch of a $5 million investment opportunity in Koning Health, the medical imaging company behind the groundbreaking Koning Vera™ 3D Breast CT Scanner. Norcross, GA - Sage Tap Poder Capital Management (STPCM) announced the official launch of a $5 million investment opportunity in Koning Health, the medical imaging company behind the groundbreaking Koning Vera™ 3D Breast CT Scanner. The raise will be facilitated through a dedicated Special Purpose Vehicle (SPV), providing accredited investors with a unique opportunity to support a category-defining technology in women's health. This SPV raise is conducted under Rule 506(c) of Regulation D and is open exclusively to verified accredited investors. Koning Health has received FDA clearance for the Koning Vera Breast CT the only imaging system of its kind that captures high-resolution, 3D images of breast tissue without the pain and distortion of compression. With this funding, Koning aims to rapidly scale its clinical footprint across the United States, expand payer reimbursement strategy, and accelerate commercial adoption among healthcare providers and radiologists. 'We are proud to be partnering with Koning Health at such a transformational moment in their growth journey. This offering gives our investor network access to a medtech company that is not only commercially active and FDA-approved for diagnostic 3D breast imaging, but also solving a decades-old pain point in women's healthcare by delivering high-resolution images without compression or discomfort,' said Kirk Honour, Managing Partner at STPCM. Koning's unique approach replaces the decades-old standard of painful breast compression with a fast, comfortable, and patient-friendly scan that captures a full 360-degree view of breast tissue in 7 seconds per breast ideal for dense tissue, calcification detection, and routine imaging. 'Koning is redefining how we approach breast imaging and STPCM is honored to play a strategic role in bringing this innovation to more clinics and patients,' added Honour. Investors interested in learning more about the opportunity can contact Kirk Honour at or call 888-558-5228 x803. About Sage Tap Poder Capital Management (STPCM) Sage Tap Poder Capital Management is a boutique investment firm dedicated to sourcing and structuring opportunities in high-growth private companies. Through its SPV model, STPCM empowers accredited investors to participate in transformational ventures typically reserved for institutional capital. Learn more at About Koning Health Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Vera Breast CT. Koning's vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue. The Koning Vera is expected to optimize early disease detection, diagnosis, and intervention by the clinician. For more information, please visit Koning's website. Media Contact Company Name: Sage Tap Poder Contact Person: Kirk Honour Email: Send Email Phone: 888-558-5228 x803 Address: 300 SOUTHARD ST STE 207 City: KEY WEST State: Florida Country: United States Website:
Yahoo
22-05-2025
- Business
- Yahoo
Koning Health Announces Series C Raise Through Strategic Partnership with Sage Tap Poder
NORCROSS, Ga., May 22, 2025 /PRNewswire/ -- Koning Health, the commercial-stage medical imaging company behind the revolutionary Vera Scan, announced the launch of its official Series C fundraising round in coordination with Sage Tap Poder SPV. The raise is being conducted as a Rule 506(c) offering under Regulation D and is open exclusively to verified accredited investors. Sage Tap Poder's SPV (special purpose vehicle) will directly invest in Koning, supporting the company's next phase of growth as it scales the rollout of the Koning Vera Breast CT (Koning Vera)—the first and only FDA-approved 3D breast imaging system for diagnostic use that delivers high-resolution images without compression or discomfort. "This Series C round marks a major milestone in our mission to transform breast imaging and empower women with a more accurate, comfortable, and accessible alternative to traditional mammography," said Matthew Stack, CFO of Koning. "Partnering with Sage Tap Poder allows us to bring a broader base of accredited investors into the Koning family at a pivotal time in our commercial expansion." The funding will accelerate deployment of the Koning Vera in clinics and hospitals across the US, drive reimbursement strategy and adoption among radiologists, and fuel ongoing innovation in 3D imaging technology. Koning's unique approach replaces the decades-old standard of painful breast compression with a fast, comfortable, and patient-friendly scan that captures a full 360-degree view of breast tissue in 7 seconds per breast—ideal for dense tissue, calcification detection, and routine imaging. "We're proud to support a company that's redefining women's health through breakthrough imaging technology," said Kirk Honour, Managing Partner at Sage Tap Poder. "This opportunity gives accredited investors the chance to invest in a category-defining medical device company with strong commercial traction and a clear path to scale." About Koning Health About Koning: Koning is a global Health Technology company focused on improving the breast imaging industry with its patented Koning Vera Breast CT. Koning's vision is to create a revolution in medical imaging through advanced computed tomography technology that dramatically improves the way clinicians visualize and evaluate breast tissue. The Koning Vera is expected to optimize early disease detection, diagnosis, and intervention by the clinician. For more information, please visit Koning's website. Accredited investors interested in participating in the offering can contact Kirk Honour at or 888-558-5228 x803 to learn more about the opportunity. View original content to download multimedia: SOURCE KONING CORPORATION
